Alona Paz

1.7k total citations
40 papers, 769 citations indexed

About

Alona Paz is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Alona Paz has authored 40 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 12 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Alona Paz's work include Travel-related health issues (7 papers), Lysosomal Storage Disorders Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Alona Paz is often cited by papers focused on Travel-related health issues (7 papers), Lysosomal Storage Disorders Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Alona Paz collaborates with scholars based in Israel, United States and South Africa. Alona Paz's co-authors include Israel Potasman, Majed Odeh, Ofer Nativ, Moti Grupper, Neora Pick, Raul Chertkoff, Gilad E. Amiel, Boaz Moskovitz, Michał Luntz and Galia Rahav and has published in prestigious journals such as Blood, Gastroenterology and Clinical Infectious Diseases.

In The Last Decade

Alona Paz

38 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alona Paz Israel 14 213 140 130 120 111 40 769
Laura Espinosa Spain 21 188 0.9× 220 1.6× 54 0.4× 159 1.3× 201 1.8× 57 1.2k
Simone Schüller Switzerland 19 225 1.1× 49 0.3× 74 0.6× 140 1.2× 44 0.4× 70 912
Geneviève Côté Canada 16 274 1.3× 269 1.9× 27 0.2× 226 1.9× 69 0.6× 36 1.1k
Bjorn L. Herpers Netherlands 18 322 1.5× 265 1.9× 86 0.7× 324 2.7× 63 0.6× 36 960
Rozenn Le Berre France 21 269 1.3× 232 1.7× 66 0.5× 253 2.1× 103 0.9× 79 1.5k
Sei Takahashi Japan 14 95 0.4× 206 1.5× 51 0.4× 145 1.2× 65 0.6× 46 1.0k
Antonio Mastroianni Italy 18 257 1.2× 109 0.8× 48 0.4× 318 2.6× 133 1.2× 99 886
Archana Thomas United States 13 165 0.8× 227 1.6× 48 0.4× 234 1.9× 152 1.4× 27 906
John D. Snyder United States 15 186 0.9× 113 0.8× 238 1.8× 144 1.2× 54 0.5× 24 973
Christína Nilsson Sweden 15 174 0.8× 171 1.2× 68 0.5× 90 0.8× 148 1.3× 24 962

Countries citing papers authored by Alona Paz

Since Specialization
Citations

This map shows the geographic impact of Alona Paz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alona Paz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alona Paz more than expected).

Fields of papers citing papers by Alona Paz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alona Paz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alona Paz. The network helps show where Alona Paz may publish in the future.

Co-authorship network of co-authors of Alona Paz

This figure shows the co-authorship network connecting the top 25 collaborators of Alona Paz. A scholar is included among the top collaborators of Alona Paz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alona Paz. Alona Paz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vega‐Morales, David, Fedra Irazoque-Palazuelos, I. J. Colunga-Pedraza, et al.. (2023). AB1358 BIOLOGIC TREATMENT SUSPENSION AND ASSOCIATED FACTORS IN PATIENTS WITH RHEUMATIC DISEASES DURING THE COVID-19 PANDEMIC: DATA FROM MEXICAN ADVERSE REGISTRY (BIOBADAMEX). Annals of the Rheumatic Diseases. 82. 1909–1910. 1 indexed citations
2.
Somri, Mostafa, et al.. (2023). Removal of Contaminated Personal Protective Equipment With and Without Supervision. A Randomized Crossover Simulation-Based Study. Simulation in Healthcare The Journal of the Society for Simulation in Healthcare. 19(3). 137–143. 2 indexed citations
3.
Najjar‐Debbiny, Ronza, Bibiana Chazan, M. Todd Greene, et al.. (2022). Healthcare-associated infection prevention and control practices in Israel: results of a national survey. BMC Infectious Diseases. 22(1). 739–739. 4 indexed citations
4.
Almon, Einat, Yoseph Shaaltiel, Wisam Sbeit, et al.. (2020). Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis. Journal of Clinical Gastroenterology. 55(2). 134–140. 17 indexed citations
5.
Odeh, Majed, et al.. (2019). Delirium induced by levofloxacin. Journal of Clinical Neuroscience. 66. 262–264. 3 indexed citations
6.
Elias, Nizar, et al.. (2018). Acute Delirium Associated With Levofloxacin. Journal of Clinical Medicine Research. 10(9). 725–727. 6 indexed citations
7.
Zimran, Ari, Aya Abrahamov, Peter A. Cooper, et al.. (2015). Long-term safety and efficacy of taliglucerase alfa in pediatric patients with Gaucher disease who were treatment-naïve previously treated with immiglucerase. Molecular Genetics and Metabolism. 114(2). S129–S129. 1 indexed citations
8.
Zimran, Ari, Aya Abrahamov, Deborah Elstein, et al.. (2014). Safety and efficacy of two dose levels of taliglucerase alfa in pediatric patients with Gaucher disease. Blood Cells Molecules and Diseases. 54(1). 9–16. 25 indexed citations
9.
Ben‐Ami, Ronen, Galia Rahav, Hila Elinav, et al.. (2012). Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel. Clinical Microbiology and Infection. 19(8). 752–756. 19 indexed citations
10.
Paz, Alona, et al.. (2007). Typhoid fever in travelers: Time for reassessment. European Journal of Internal Medicine. 18(2). 150–151. 4 indexed citations
11.
Paz, Alona, et al.. (2006). Psychiatric Problems in Returning Travelers: Features and Associations. Journal of Travel Medicine. 8(5). 243–246. 22 indexed citations
12.
Segev, Lior, Alona Paz, & Israel Potasman. (2006). Drug Abuse in Travelers to Southeast Asia: An On-Site Study. Journal of Travel Medicine. 12(4). 205–209. 13 indexed citations
13.
Paz, Alona, Siegal Sadetzki, & Israel Potasman. (2006). High Rates of Substance Abuse among Long-term Travelers to the Tropics: an Interventional Study. Journal of Travel Medicine. 11(2). 75–81. 9 indexed citations
14.
Paz, Alona, et al.. (2005). Late vaccination against yellow fever of travelers visiting endemic countries. Travel Medicine and Infectious Disease. 4(2). 94–98. 7 indexed citations
15.
Paz, Alona, et al.. (2004). Leptospirosis masquerading as infectious enteritis. Travel Medicine and Infectious Disease. 2(2). 89–91. 2 indexed citations
16.
Paz, Alona, et al.. (2003). Pulmonary coccidioidomycosis acquired during travel—a diagnostic and therapeutic challenge. Travel Medicine and Infectious Disease. 1(1). 53–57. 3 indexed citations
17.
Paz, Alona & Israel Potasman. (2002). <i>Mycoplasma</i>-Associated Carditis. Cardiology. 97(2). 83–88. 36 indexed citations
18.
Potasman, Israel, Alona Paz, & Majed Odeh. (2002). Infectious Outbreaks Associated with Bivalve Shellfish Consumption: A Worldwide Perspective. Clinical Infectious Diseases. 35(8). 921–928. 312 indexed citations
19.
Paz, Alona, R. Gonen, & Israel Potasman. (2001). Candida Sepsis Following Transcervical Chorionic Villi Sampling. Infectious Diseases in Obstetrics and Gynecology. 9(3). 147–148. 4 indexed citations
20.
Ephros, Moshe, Alona Paz, & Charles L. Jaffe. (1994). Asymptomatic visceral leishmaniasis in Israel. Transactions of the Royal Society of Tropical Medicine and Hygiene. 88(6). 651–652. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Espinosa Breakdown of academic impact, for papers by Simone Schüller Breakdown of academic impact, for papers by Geneviève Côté Breakdown of academic impact, for papers by Bjorn L. Herpers Breakdown of academic impact, for papers by Rozenn Le Berre Breakdown of academic impact, for papers by Sei Takahashi Breakdown of academic impact, for papers by Antonio Mastroianni Breakdown of academic impact, for papers by Archana Thomas Breakdown of academic impact, for papers by John D. Snyder Breakdown of academic impact, for papers by Christína Nilsson
Rankless by CCL
2026